Home » Newsletters » BioWorld Science

BioWorld Science

March 12, 1997

View Archived Issues

Antibacterial agent isolated by Sanwa Kagaku

Green Cross claims hypolipidemic agents

Anthracyclines from Microbial Chemistry Research Foundation

Cell adhesion inhibitors disclosed by Nippon Shinyaku

New antibacterial agents from Daiichi

Bayer claims potassium channel modulators

Activated immunoglobulins reported by Nippon Zoki

AutoImmune reports 1996 fourth-quarter and year-end financial results

Chiroscience Group 1996/7 pharmaceutical development update

Genzyme Tissue Repair reports 1996 results

ICN reports record sales, net income and EPS for 1996 and fourth quarter

ViroPharma reports 1996 financial results

Salix completes filing for ulcerative colitis treatment

Nymox and MGH collaborate on gene therapy

John Wayne Cancer Institute initiates first clinical trials on Pseudomonas exotoxin

Array Medical's Actalyke system receives FDA approval

VIMRx and Columbia University create new gene research company

Pfizer initiates clinical trial in panic disorder

Genelabs Technologies and BMS reach agreement in Taiwan

Positive phase III results for GelTex's RenaGel

Genome Therapeutics and Versicor collaborate on new antibacterial compounds

Advanced-generation matrix HRT patch launched in U.K.

Pharmacyclic earns NCI support for anticancer compounds

Positive phase I results for new formulation of lexipafant

Zorac available in Germany

SKB's Vectavir introduced in Germany

German introduction for spirapril

Novo Nordisk and Dyax collaborate on drug discovery

First approval for naratriptan

GS-4104 enters human testing

U.S. patent for Sugen's lead cancer therapeutic

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 5, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 5, 2025.
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
Mesothelin is biomarker, potential target in arthritic bone damage
BioWorld Science
In a recent study published in Cell Reports Medicine, researchers from the Institute of Chinese Materia Medica of the China Academy of Chinese Medical Sciences...
Gene therapies aim for the big goal of edits in vivo
BioWorld Science
The field of gene therapy is experiencing major advances driven by precise editing technologies, such as base and prime editing, and by the design of increasingly...